Cargando…
Tumor response assessment by the single-lesion measurement per organ in small cell lung cancer
BACKGROUND: The criterion of two target lesions per organ in the Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1 is an arbitrary one, being supported by no objective evidence. The optimal number of target lesions per organ still needs to be investigated. We compared tumor responses...
Autores principales: | Jung, Soong Goo, Kim, Jung Han, Kim, Hyeong Su, Kim, Kyoung Ju, Yang, Ik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865608/ https://www.ncbi.nlm.nih.gov/pubmed/27199513 http://dx.doi.org/10.21147/j.issn.1000-9604.2016.02.03 |
Ejemplares similares
-
Ideal number of target lesions per organ to measure in metastatic colorectal cancer
por: KIM, HYEONG SU, et al.
Publicado: (2014) -
The Assessment of Tumor Response by Measuring the Single Largest Lesion per Organ in Metastatic Tumors: A Pooled Analysis of Previously Reported Data
por: Jang, Hyun Joo, et al.
Publicado: (2015) -
Comparison of the RECIST 1.0 and RECIST 1.1 in Non-Small Cell Lung Cancer Treated with Cytotoxic Chemotherapy
por: Choi, Hyun Chang, et al.
Publicado: (2015) -
Tumor response assessment by measuring the single largest lesion per organ in advanced non-small cell lung cancer patients treated with PD-1/PD-L1 inhibitor
por: He, Li-Na, et al.
Publicado: (2023) -
MET inhibitors in advanced non-small-cell lung cancer: a meta-analysis and review
por: Kim, Jung Han, et al.
Publicado: (2017)